Latest News, Announcements, and Press Releases

Includes an option for the global development of CDX-6114 for PKU, marking Codexis’ first partnership for an internally developed biotherapeutic product.  Codexis receives an upfront payment of $14 million and potential milestones and royalties depending on product success…

REDWOOD CITY, Calif., Aug. 31, 2017 (GLOBE NEWSWIRE) —  Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that management will present at four investment conferences in September: BioCentury 24th Annual NewsMakers in the Biotech Industry Conference on…

Product sales more than doubled versus prior-year second quarter Affirms 2017 total revenue guidance; increases full year product sales and gross margin guidance Conference call begins at 4:30 pm Eastern time today REDWOOD CITY, Calif., Aug. 09, 2017…

REDWOOD CITY, Calif.–(BUSINESS WIRE)–Aug. 8, 2017– Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, on Tuesday secured a federal court order awarding it summary judgment on 10 claims of patent infringement it brought in a lawsuit against Suzhou, China-based EnzymeWorks, Inc.…

REDWOOD CITY, Calif., Aug. 02, 2017 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that it will report second quarter 2017 financial results after market close on Wednesday, August 9, 2017. Codexis management will…

REDWOOD CITY, Calif., May 30, 2017 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that management will present at two upcoming investment conferences: 14th Annual Craig-Hallum Institutional 1×1 Investor Conference on Wednesday, May 31st…

Product sales increase 49% Highlights include signing second multiyear agreement in the food industry and initiating beta testing of first company-developed enzyme for the molecular diagnostics industry Conference call begins at 4:30 pm Eastern time today REDWOOD CITY,…

REDWOOD CITY, Calif., May 02, 2017 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that it will report first quarter 2017 financial results after market close on Tuesday, May 9, 2017. Codexis management will…

REDWOOD CITY, Calif., April 07, 2017 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading protein engineering company, today announced the pricing of an underwritten public offering of 5,500,000 shares of its common stock at a public offering price…

REDWOOD CITY, Calif., April 06, 2017 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading protein engineering company, today announced that it has commenced an underwritten public offering of shares of its common stock. All of the shares to…